| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |